Literature DB >> 19573285

Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS.

Annick Delvigne1.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a rare iatrogenic complication of ovarian stimulation occurring during the luteal phase or during early pregnancy. The prevalence of the severe form of OHSS is very low and precise analysis of this risk population is difficult. This work reviews the literature in order to identify patients at risk. Data pertaining to the epidemiology and the risk factors of OHSS in women were sought using Medline, Current Contents and PubMed. Relevant papers are summarized. After analysing the data concerning the incidence of OHSS, the pretreatment characteristics of patients were reviewed: age, body mass index, allergies, blood group and aetiology of sterility. The risk factors identified through the ovarian response to stimulation were also analysed: follicular development, oestradiol concentration and other ovarian products. In conclusion, polycystic ovary syndrome may be considered to be a risk factor for OHSS with an evidence level II. However, for other risk factors, only evidence level III could be reached. According to this lack of evidence-based data for predictive factors, all patients are to be considered as potentially at risk for OHSS and treated following to the primum non nocere principle.

Entities:  

Mesh:

Year:  2009        PMID: 19573285     DOI: 10.1016/s1472-6483(10)60040-5

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  20 in total

1.  Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment.

Authors:  Hang Wun Raymond Li; Vivian Chi Yan Lee; Pak Chung Ho; Ernest Hung Yu Ng
Journal:  J Assist Reprod Genet       Date:  2013-12-08       Impact factor: 3.412

Review 2.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

3.  Venous thromboembolism in assisted reproductive technologies: comparison between unsuccessful versus successful cycles in an Italian cohort.

Authors:  Michela Villani; Giovanni Favuzzi; Pasquale Totaro; Elena Chinni; Gennaro Vecchione; Patrizia Vergura; Lucia Fischetti; Maurizio Margaglione; Elvira Grandone
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

4.  Multiorgan failure associated with severe ovarian hyperstimulation syndrome due to inadequate protocol optimisation: a rare but avoidable complication.

Authors:  Lorraine Sheena Kasaven; Anastasia Goumenou; Kenneth Adegoke
Journal:  BMJ Case Rep       Date:  2018-03-05

5.  Thoracic endometriosis unmasked by ovarian hyperstimulation for in vitro fertilization.

Authors:  Stephanie A C Halvorson; Mari A Ricker; Alan F Barker; Phillip E Patton; Rebecca A Harrison; Alan J Hunter
Journal:  J Gen Intern Med       Date:  2012-01-11       Impact factor: 5.128

6.  Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.

Authors:  H R Nejabati; A Mota; L Farzadi; M Ghojazadeh; A Fattahi; K Hamdi; M Nouri
Journal:  J Endocrinol Invest       Date:  2016-09-23       Impact factor: 4.256

7.  Rare genetic variants potentially involved in ovarian hyperstimulation syndrome.

Authors:  Katrien Stouffs; Sari Daelemans; Samuel Santos-Ribeiro; Sara Seneca; Alexander Gheldof; Ali Sami Gürbüz; Michel De Vos; Herman Tournaye; Christophe Blockeel
Journal:  J Assist Reprod Genet       Date:  2018-11-27       Impact factor: 3.412

8.  Combination of cabergoline and embryo cryopreservation after GnRH agonist triggering prevents OHSS in patients with extremely high estradiol levels--a retrospective study.

Authors:  Yu-Hung Lin; Mei-Zen Huang; Jiann-Loung Hwang; Heng-Ju Chen; Bih-Chwen Hsieh; Lee-Wen Huang; Chii-Ruey Tzeng; Kok-Min Seow
Journal:  J Assist Reprod Genet       Date:  2013-04-20       Impact factor: 3.412

9.  Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

Authors:  Ya-Qin Wang; Jin Luo; Wang-Min Xu; Qin-Zhen Xie; Wen-Jie Yan; Geng-Xiang Wu; Jin Yang
Journal:  J Ovarian Res       Date:  2015-09-23       Impact factor: 4.234

10.  Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles.

Authors:  Srisailesh Vitthala; Jerome Bouaziz; Amanda Tozer; Ariel Zosmer; Talha Al-Shawaf
Journal:  Int J Endocrinol       Date:  2012-02-12       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.